Skip to main content
Clinical Trials/NCT05209724
NCT05209724
Unknown
Not Applicable

Remote Monitoring of Home Exercise in Peripheral Arterial Disease

Dallas VA Medical Center1 site in 1 country56 target enrollmentNovember 21, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Peripheral Arterial Disease
Sponsor
Dallas VA Medical Center
Enrollment
56
Locations
1
Primary Endpoint
Change in 6 minute walk test distance between groups
Last Updated
4 years ago

Overview

Brief Summary

Many patients with blockages in the arteries in their legs (peripheral arterial disease, "PAD") suffer from pain in their legs when walking. Exercise therapy is known to decrease pain levels as well as increase the distance that patients with PAD can walk. The purpose of this study is to understand whether home exercise using a digital exercise monitoring system (LIVMOR) with provider supervision/ feedback will improve walking distance compared to those undergoing home exercise using the same monitoring system but without provider supervision/ feedback.

Registry
clinicaltrials.gov
Start Date
November 21, 2021
End Date
June 2023
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Subhash Banerjee

Principal Investigator

Dallas VA Medical Center

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of PAD (based on ABI \<0.9 in either leg or prior intervention) with mild/moderate claudication

Exclusion Criteria

  • Prior above ankle amputation
  • Wheelchair bound
  • Inability to walk \>200m during 6 min walk test
  • Use of walking aid other than cane
  • Walking impairment for reason other than PAD
  • Critical limb ischemia
  • Planned vascular surgery within next 3 months, recent surgery within past 3 months

Outcomes

Primary Outcomes

Change in 6 minute walk test distance between groups

Time Frame: 12 weeks

Change in 6 minute walk test distance between groups

Secondary Outcomes

  • Change in VascuQOL-6 (VQ6) quality of life survey(12 weeks)
  • Change in Walking Impairment Questionnaire score(12 weeks)

Study Sites (1)

Loading locations...

Similar Trials